Cargando…

Variants influencing age at diagnosis of HNF1A-MODY

BACKGROUND: HNF1A-MODY is a monogenic form of diabetes caused by variants in the HNF1A gene. Different HNF1A variants are associated with differences in age of disease onset, but other factors are postulated to influence this trait. Here, we searched for genetic variants influencing age of HNF1A-MOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ludwig-Słomczyńska, Agnieszka H., Seweryn, Michał T., Radkowski, Piotr, Kapusta, Przemysław, Machlowska, Julita, Pruhova, Stepanka, Gasperikova, Daniela, Bellanne-Chantelot, Christine, Hattersley, Andrew, Kandasamy, Balamurugan, Letourneau-Freiberg, Lisa, Philipson, Louis, Doria, Alessandro, Wołkow, Paweł P., Małecki, Maciej T., Klupa, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476297/ https://www.ncbi.nlm.nih.gov/pubmed/36104811 http://dx.doi.org/10.1186/s10020-022-00542-0

Ejemplares similares

Qualitative Parameters of the Colonic Flora in Patients with HNF1A-MODY Are Different from Those Observed in Type 2 Diabetes Mellitus
por: Mrozinska, Sandra, et al.
Publicado: (2016)

Two Cases of Diabetic Ketoacidosis in HNF1A-MODY Linked to Severe Dehydration: Is it time to change the diagnostic criteria for MODY?
por: Pruhova, Stepanka, et al.
Publicado: (2013)

Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study
por: Locke, Jonathan M., et al.
Publicado: (2021)

Comparison of Glomerular Filtration Rate Estimation from Serum Creatinine and Cystatin C in HNF1A-MODY and Other Types of Diabetes
por: Szopa, Magdalena, et al.
Publicado: (2015)

Negative pressure wound therapy in the treatment of diabetic foot ulcers may be mediated through differential gene expression
por: Borys, S., et al.
Publicado: (2018)

A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus
por: Hohendorff, J., et al.
Publicado: (2017)

Cystatin C is not a good candidate biomarker for HNF1A-MODY
por: Nowak, Natalia, et al.
Publicado: (2012)

Assessment of Newly Proposed Clinical Criteria to Identify HNF1A MODY in Patients with an Initial Diagnosis of Type 1 or Type 2 Diabetes Mellitus
por: Grzanka, Malgorzata, et al.
Publicado: (2016)

Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2)
por: Gregory, Justin M., et al.
Publicado: (2019)

Circulating ghrelin level is higher in HNF1A–MODY and GCK–MODY than in polygenic forms of diabetes mellitus
por: Nowak, Natalia, et al.
Publicado: (2015)

Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young
por: Ellard, S., et al.
Publicado: (2008)

High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes
por: McDonald, Tim J., et al.
Publicado: (2011)

Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts
por: Mirshahi, Uyenlinh L, et al.
Publicado: (2022)

DNA methylation analysis of negative pressure therapy effect in diabetic foot ulcers
por: Ludwig-Slomczynska, A H, et al.
Publicado: (2019)

Double Heterozygous Mutations Involving Both HNF1A/MODY3 and HNF4A/MODY1 Genes: A case report
por: Forlani, Gabriele, et al.
Publicado: (2010)

Long-Term Follow-Up of Oral Glucose Tolerance Test–Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)
por: Martin, Delphine, et al.
Publicado: (2008)

An Atypical HNF4A Mutation Which Does Not Conform to the Classic Presentation of HNF4A-MODY
por: Spiro, Andrew J., et al.
Publicado: (2018)

Circulating CD36 Is Reduced in HNF1A-MODY Carriers
por: Bacon, Siobhan, et al.
Publicado: (2013)

Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY
por: Oosterom, Nicole, et al.
Publicado: (2022)

The Gut Microbiota Profile According to Glycemic Control in Type 1 Diabetes Patients Treated with Personal Insulin Pumps
por: Mrozinska, Sandra, et al.
Publicado: (2021)

Granuloma annulare and necrobiosis lipoidica in a patient with HNF1A-MODY
por: Brandes, Gabriela Irene Garcia, et al.
Publicado: (2022)

Genetic and Clinical Characterization of Patients with HNF1B-Related MODY in Croatia
por: Baretić, Maja, et al.
Publicado: (2023)

Chronic Mild Hyperglycemia in GCK-MODY Patients Does Not Increase Carotid Intima-Media Thickness
por: Pruhova, Stepanka, et al.
Publicado: (2013)

The transcriptome-wide association search for genes and genetic variants which associate with BMI and gestational weight gain in women with type 1 diabetes
por: Ludwig-Słomczyńska, Agnieszka H., et al.
Publicado: (2021)

High-Throughput Sequencing of Gastric Cancer Patients: Unravelling Genetic Predispositions Towards an Early-Onset Subtype
por: Machlowska, Julita, et al.
Publicado: (2020)

Status of CHEK2 and p53 in patients with early-onset and conventional gastric cancer
por: Machlowska, Julita, et al.
Publicado: (2021)

A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations
por: Szopa, Magdalena, et al.
Publicado: (2019)

Patterns of gene expression characterize T1 and T3 clear cell renal cell carcinoma subtypes
por: Borys, Agnieszka M., et al.
Publicado: (2019)

Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY
por: Broome, David T., et al.
Publicado: (2020)

Incidence of HNF1A and GCK MODY Variants in a South African Population
por: Matsha, Tandi E, et al.
Publicado: (2020)

Contribution of a Novel B3GLCT Variant to Peters Plus Syndrome Discovered by a Combination of Next-Generation Sequencing and Automated Text Mining
por: Totoń-Żurańska, Justyna, et al.
Publicado: (2019)

Mitochondrial GWAS and association of nuclear – mitochondrial epistasis with BMI in T1DM patients
por: Ludwig-Słomczyńska, Agnieszka H., et al.
Publicado: (2020)

Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY)
por: Boesgaard, Trine W, et al.
Publicado: (2010)

MODY probability calculator for GCK and HNF1A screening in a multiethnic background population
por: Tarantino, Roberta Magalhães, et al.
Publicado: (2019)

Insights from basic adjunctive examinations of GCK‐MODY, HNF1A‐MODY, and type 2 diabetes: A systemic review and meta‐analysis
por: Liu, Jing, et al.
Publicado: (2023)

Two New Mutations in the CEL Gene Causing Diabetes and Hereditary Pancreatitis: How to Correctly Identify MODY8 Cases
por: El Jellas, Khadija, et al.
Publicado: (2021)

SUN-143 Does a Monogenic Diabetes Diagnosis Impact Quality of Life?
por: Harris, Anastasia, et al.
Publicado: (2019)

A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY
por: Kettunen, Jarno L. T., et al.
Publicado: (2021)

HNF1B-MODY Masquerading as Type 1 Diabetes: A Pitfall in the Etiological Diagnosis of Diabetes
por: Francis, Youmna, et al.
Publicado: (2022)

Clinical Characteristics of Patients With HNF1-alpha MODY: A Literature Review and Retrospective Chart Review
por: Zhao, Qinying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0mcbqmr4n28r9bigqd2m1lve9p